Patients With Breast Cancer, HIV More Likely to Experience Suboptimal Adjuvant Chemotherapy Delivery
The researchers noted the need for strategies to better support women living with HIV with breast cancer during toxic therapies to improve outcomes among this growing population. With the introduction ...
ORLANDO, Fla., May 22, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing its novel patented, affordable, non ...
WHEN pharmacist Stephen Kemp talks about HIV work, there is no hesitation in his voice. He remembers the moment he walked into the HIV Treatment Centre more than a decade ago and felt something shift.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback